Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpelisib plus Ganitumab in advanced solid tumors
NCT01708161Phase 2Terminated
- Sponsor
- Novartis
- Start
- Nov 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of alpelisib in breast cancer, ovarian cancer, solid tumor, sponsored by Novartis. Started Nov 2012; status: terminated.
02
Drugs
alpelisib
03
Conditions
breast cancerovarian cancersolid tumor
Beyond the preview
Go deeper on NCT01708161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01708161.